RU2329266C2 - Ингибиторы крузипаина и других цистеинпротеаз - Google Patents

Ингибиторы крузипаина и других цистеинпротеаз Download PDF

Info

Publication number
RU2329266C2
RU2329266C2 RU2003125270/04A RU2003125270A RU2329266C2 RU 2329266 C2 RU2329266 C2 RU 2329266C2 RU 2003125270/04 A RU2003125270/04 A RU 2003125270/04A RU 2003125270 A RU2003125270 A RU 2003125270A RU 2329266 C2 RU2329266 C2 RU 2329266C2
Authority
RU
Russia
Prior art keywords
alkyl
compound according
group
phenyl
disease
Prior art date
Application number
RU2003125270/04A
Other languages
English (en)
Russian (ru)
Other versions
RU2003125270A (ru
Inventor
Мартин КВИБЕЛЛ (GB)
Мартин КВИБЕЛЛ
Original Assignee
Амура Терапьютикс Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0101179A external-priority patent/GB0101179D0/en
Application filed by Амура Терапьютикс Лимитед filed Critical Амура Терапьютикс Лимитед
Publication of RU2003125270A publication Critical patent/RU2003125270A/ru
Application granted granted Critical
Publication of RU2329266C2 publication Critical patent/RU2329266C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
RU2003125270/04A 2001-01-17 2002-01-17 Ингибиторы крузипаина и других цистеинпротеаз RU2329266C2 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0101179A GB0101179D0 (en) 2001-01-17 2001-01-17 Biologically active compounds
GB0101179.0 2001-01-17
US27535901P 2001-03-13 2001-03-13
US60/275,359 2001-03-13

Publications (2)

Publication Number Publication Date
RU2003125270A RU2003125270A (ru) 2005-02-20
RU2329266C2 true RU2329266C2 (ru) 2008-07-20

Family

ID=26245571

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2003125270/04A RU2329266C2 (ru) 2001-01-17 2002-01-17 Ингибиторы крузипаина и других цистеинпротеаз

Country Status (20)

Country Link
US (2) US7425562B2 (cg-RX-API-DMAC7.html)
EP (1) EP1362052B1 (cg-RX-API-DMAC7.html)
JP (1) JP4608183B2 (cg-RX-API-DMAC7.html)
KR (1) KR100860067B1 (cg-RX-API-DMAC7.html)
CN (1) CN1269822C (cg-RX-API-DMAC7.html)
AT (1) ATE356130T1 (cg-RX-API-DMAC7.html)
AU (1) AU2002219397B2 (cg-RX-API-DMAC7.html)
BR (1) BR0206501A (cg-RX-API-DMAC7.html)
CA (1) CA2436462C (cg-RX-API-DMAC7.html)
CY (1) CY1106640T1 (cg-RX-API-DMAC7.html)
DE (1) DE60218633T2 (cg-RX-API-DMAC7.html)
DK (1) DK1362052T3 (cg-RX-API-DMAC7.html)
ES (1) ES2281516T3 (cg-RX-API-DMAC7.html)
IL (2) IL156774A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA03006224A (cg-RX-API-DMAC7.html)
NO (1) NO328208B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ526913A (cg-RX-API-DMAC7.html)
PT (1) PT1362052E (cg-RX-API-DMAC7.html)
RU (1) RU2329266C2 (cg-RX-API-DMAC7.html)
WO (1) WO2002057270A1 (cg-RX-API-DMAC7.html)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7030116B2 (en) 2000-12-22 2006-04-18 Aventis Pharmaceuticals Inc. Compounds and compositions as cathepsin inhibitors
WO2002051983A2 (en) 2000-12-22 2002-07-04 Axys Pharmaceuticals, Inc. Novel compounds and compositions as cathepsin inhibitors
MXPA04002282A (es) 2001-09-14 2005-03-07 Axis Pharmaceutical Inc Nuevos compuestos y preparaciones como inhibidores de la catepsina.
EP1446392A1 (en) 2001-11-14 2004-08-18 Aventis Pharmaceuticals, Inc. Oligopeptides and compositions containing them as cathepsin s inhibitors
CN100354276C (zh) * 2002-07-16 2007-12-12 阿姆拉医疗有限公司 生物活性化合物
US7399765B2 (en) * 2003-09-19 2008-07-15 Abbott Laboratories Substituted diazabicycloalkane derivatives
SE0400022D0 (sv) * 2004-01-08 2004-01-08 Medivir Ab New compounds
DE602005019971D1 (de) * 2004-01-08 2010-04-29 Medivir Ab Inhibitoren von cysteinprotease
JP2005350417A (ja) * 2004-06-11 2005-12-22 Dai Ichi Seiyaku Co Ltd 還元的エーテル化法を用いたピロリジン誘導体の製造法
PL1865940T3 (pl) * 2005-03-21 2013-06-28 Virobay Inc Alfa-ketoamidowe związki jako inhibitory proteaz cysteinowych
GB0513839D0 (en) * 2005-07-07 2005-08-10 Medivir Ab Cysteine protease inhibitors
GB0513840D0 (en) * 2005-07-07 2005-08-10 Medivir Ab Cysteine protease inhibitors
GB0614037D0 (en) * 2006-07-14 2006-08-23 Amura Therapeutics Ltd Compounds
GB0614044D0 (en) * 2006-07-14 2006-08-23 Amura Therapeutics Ltd Compounds
GB0614053D0 (en) * 2006-07-14 2006-08-23 Amura Therapeutics Ltd Compounds
GB0614052D0 (en) * 2006-07-14 2006-08-23 Amura Therapeutics Ltd Compounds
GB0614073D0 (en) 2006-07-14 2006-08-23 Amura Therapeutics Ltd Compounds
GB0614042D0 (en) 2006-07-14 2006-08-23 Amura Therapeutics Ltd Compounds
GB0614046D0 (en) 2006-07-14 2006-08-23 Amura Therapeutics Ltd Compounds
WO2008114054A1 (en) * 2007-03-19 2008-09-25 Medivir Ab Protease inhibitors
US7893067B2 (en) * 2007-06-27 2011-02-22 Medivir Ab Cysteine protease inhibitors
JP5587790B2 (ja) * 2008-01-09 2014-09-10 アミュラ セラピューティクス リミティド 化合物
GB0804702D0 (en) * 2008-03-13 2008-04-16 Amura Therapeutics Ltd Compounds
GB0804701D0 (en) 2008-03-13 2008-04-16 Amura Therapeutics Ltd Compounds
US9409880B2 (en) 2011-01-20 2016-08-09 The Regents Of The University Of Colorado, A Body Corporate Modulators of TLR3/dsRNA complex and uses thereof
CN106963760A (zh) * 2012-08-30 2017-07-21 国立大学法人东京大学 体内寄生虫防治剂在制备防治体内寄生虫的药物中的用途
CN106279188A (zh) * 2016-07-21 2017-01-04 青岛科技大学 一种多取代呋喃并[2,3‑b]吡咯衍生物的制备方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1440345A3 (ru) * 1986-01-17 1988-11-23 Байер Аг (Фирма) Способ получени производных дигидропиридинлактола
RU96114986A (ru) * 1993-12-15 1998-10-20 Мерк энд Ко, Инк. Ингибиторы н1v протеазы
WO1998050533A1 (en) * 1997-05-06 1998-11-12 Smithkline Beecham Corporation Protease inhibitors
WO2000069855A2 (en) * 1999-05-18 2000-11-23 Medivir Uk Limited Furanone derivatives as inhibitors of cathepsin s

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3652574A (en) * 1970-04-01 1972-03-28 Abbott Lab Certain 1 2 3 4 - tetrahydro-5h-pyrido (4 3-b)indoles and the corresponding 1 2 3 4-tetrahydro-9h-pyrido(3 4-b)indoles and derivatives thereof
RU2137768C1 (ru) * 1993-12-15 1999-09-20 Мерк энд Ко, Инк. Ингибиторы hiv протеазы
DZ2285A1 (fr) 1996-08-08 2002-12-25 Smithkline Beecham Corp Inhibiteurs de protéase de la cystéine.
EP0923535A4 (en) 1996-08-28 2001-01-10 Smithkline Beecham Corp CYSTEINE PROTEASE INHIBITORS
ZA9711537B (en) 1996-12-23 1998-06-25 Athena Neurosciences Inc Eli L Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting ß-amyloid peptide release and/or its synthesis by use of such compounds.
MA26618A1 (fr) 1998-04-09 2004-12-20 Smithkline Beecham Corp Composes et compositions pharmaceutiques pour le traitement du paludisme
CO5150165A1 (es) 1998-11-13 2002-04-29 Smithkline Beecham Plc Inhibidores de proteasa: tipo catepsina k
IL155961A0 (en) 2000-11-17 2003-12-23 Medivir Uk Ltd Cysteine protease inhibitors
WO2002051983A2 (en) 2000-12-22 2002-07-04 Axys Pharmaceuticals, Inc. Novel compounds and compositions as cathepsin inhibitors

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1440345A3 (ru) * 1986-01-17 1988-11-23 Байер Аг (Фирма) Способ получени производных дигидропиридинлактола
RU96114986A (ru) * 1993-12-15 1998-10-20 Мерк энд Ко, Инк. Ингибиторы н1v протеазы
WO1998050533A1 (en) * 1997-05-06 1998-11-12 Smithkline Beecham Corporation Protease inhibitors
WO2000069855A2 (en) * 1999-05-18 2000-11-23 Medivir Uk Limited Furanone derivatives as inhibitors of cathepsin s

Also Published As

Publication number Publication date
CN1269822C (zh) 2006-08-16
KR20030075161A (ko) 2003-09-22
DE60218633T2 (de) 2008-02-21
CY1106640T1 (el) 2012-01-25
WO2002057270A1 (en) 2002-07-25
NO328208B1 (no) 2010-01-11
ES2281516T3 (es) 2007-10-01
US7425562B2 (en) 2008-09-16
DE60218633D1 (de) 2007-04-19
ATE356130T1 (de) 2007-03-15
BR0206501A (pt) 2004-01-13
DK1362052T3 (da) 2007-07-09
CA2436462A1 (en) 2002-07-25
RU2003125270A (ru) 2005-02-20
KR100860067B1 (ko) 2008-09-24
EP1362052A1 (en) 2003-11-19
IL156774A (en) 2008-08-07
US20090247471A1 (en) 2009-10-01
EP1362052B1 (en) 2007-03-07
HK1060729A1 (en) 2004-08-20
PT1362052E (pt) 2007-04-30
JP4608183B2 (ja) 2011-01-05
AU2002219397B2 (en) 2008-02-14
NZ526913A (en) 2004-12-24
CN1486320A (zh) 2004-03-31
IL156774A0 (en) 2004-02-08
NO20033220D0 (no) 2003-07-16
MXPA03006224A (es) 2004-10-15
NO20033220L (no) 2003-09-17
CA2436462C (en) 2011-07-05
JP2004518674A (ja) 2004-06-24
US20040138250A1 (en) 2004-07-15

Similar Documents

Publication Publication Date Title
CA3000661C (en) Thalidomide analogs and methods of use
RU2003125270A (ru) Ингибиторы крузипаина и других цистеинпротеаз
JP2004518674A5 (cg-RX-API-DMAC7.html)
RU2006109467A (ru) Способы лечения рака с использованием ингибиторов hdac
EA200500985A1 (ru) Твердая лекарственная форма для перорального применения
JP2010539167A (ja) 免疫機能を調節する組成物および方法
KR890008155A (ko) 신규인 유도체, 그 제조방법 및 의약에서의 사용
RU2007124329A (ru) ПРОИЗВОДНЫЕ 5-ГИДРОКСИБЕНЗОТИАЗОЛА В КАЧЕСТВЕ АГОНИСТОВ β2 АДРЕНОРЕЦЕПТОРОВ
NO172580C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte n-(1-alkyl-3-hydroksy-4-piperidinyl)benzamider
RU2017106172A (ru) Применение антагонистов cxcr2 для предотвращения и/или лечения периферической невропатии, вызванной химиотерапией (cipn)
RU2011154329A (ru) Композиции на основе бориновой кислоты
AR039190A1 (es) Derivados de benzofurano, composicion farmaceutica y medicamento que comprende el compuesto
HUP0100520A1 (hu) Csontfelszívódást és sejtösszenövést gátló új szulfonamidszármazékok
EP2037736A1 (en) Methods for treating cystic kidney diseases
US6562858B2 (en) Method for treating depression
JPWO2008047880A1 (ja) 関節リウマチ治療薬
RU2009105097A (ru) ТЕТРАГИДРОФУРО(3,2-b)ПИРРОЛ-3-ОНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ КАТЕПСИНА К
KR20120083356A (ko) Hiv 감염 치료를 위한 n-히드록시벤즈아미드의 유도체
Pappas et al. Importance of the locus coeruleus and involvement of α-adrenergic receptors in the post-decapitation reflex in the rat
JP2004520365A5 (cg-RX-API-DMAC7.html)
KR20210121989A (ko) 베타코로나바이러스 감염을 예방하기 위한 조성물
DK0893121T3 (da) Flydende oral medicinopløsning
ES2836724T3 (es) Uso de estiripentol y sus derivados para disminuir la concentración de oxalato urinario en un individuo
Nev et al. Interleukin-6 responses in Red Sokoto bucks following orchidectomy, burdizzo castration and in-situ spermatic cord ligation
CN1283251C (zh) 用于预防人类和动物寄生虫感染的驱虫药

Legal Events

Date Code Title Description
PC41 Official registration of the transfer of exclusive right

Effective date: 20131015

MM4A The patent is invalid due to non-payment of fees

Effective date: 20180118